Sculponeatin O is primarily investigated for its potential anti-inflammatory and neuroprotective properties. It has shown promise in preclinical studies targeting neurodegenerative conditions such as Alzheimer’s and Parkinson’s diseases by modulating oxidative stress and inhibiting key inflammatory pathways in neural tissues. Its ability to cross the blood-brain barrier enhances its suitability for central nervous system therapeutics. Additionally, Sculponeatin O exhibits antimicrobial activity against certain Gram-positive bacteria, suggesting possible use in treating bacterial infections, particularly those involving biofilm formation. Research is ongoing to explore its role in cancer therapy, where it may help suppress tumor cell proliferation through induction of apoptosis. Due to its natural origin and low cytotoxicity in preliminary assays, it is considered a candidate for development in nutraceuticals and cosmeceuticals aimed at anti-aging and skin protection formulations.